{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:23Z","timestamp":1791332543114,"version":"4.3.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.metabol.2011.05.016","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T17:23:03Z","timestamp":1310145783000},"page":"1211-1221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women"],"prefix":"10.1016","volume":"60","author":[{"given":"Elizabeth","family":"Sienkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faidon","family":"Magkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Aronis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Brinkoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Chamberland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi M.","family":"Arampatzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Koniaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2011.05.016_bb0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2265.2008.03237.x","article-title":"Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study","volume":"69","author":"Christo","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2011.05.016_bb0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jcem.82.1.3840","article-title":"Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea","volume":"82","author":"Laughlin","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4085\/1062-6050-45.3.243","article-title":"Relationships among injury and disordered eating, menstrual dysfunction, and low bone mineral density in high school athletes: a prospective study","volume":"45","author":"Rauh","year":"2010","journal-title":"J Athl Train"},{"key":"10.1016\/j.metabol.2011.05.016_bb0020","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1152\/jappl.2000.88.6.2037","article-title":"Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional, and endocrine factors","volume":"88","author":"Thong","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2011.05.016_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.2000.tb06228.x","article-title":"Role of leptin in reproduction","volume":"900","author":"Mantzoros","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2011.05.016_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMcp0912024","article-title":"Clinical practice. Functional hypothalamic amenorrhea","volume":"363","author":"Gordon","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0035","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/jbmr.63","article-title":"Cross-sectional evidence of suppressed bone mineral accrual among female adolescent runners","volume":"25","author":"Barrack","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2011.05.016_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jama.1984.03340290040017","article-title":"Decreased spinal mineral content in amenorrheic women","volume":"251","author":"Cann","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2011.05.016_bb0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198408023110501","article-title":"Bone mineral content of amenorrheic and eumenorrheic athletes","volume":"311","author":"Drinkwater","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0050","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1542\/peds.2007-2392","article-title":"Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects","volume":"121","author":"Christo","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.metabol.2011.05.016_bb0055","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jcem.87.6.8574","article-title":"Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa","volume":"87","author":"Grinspoon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00198-007-0518-6","article-title":"Strategies to reverse bone loss in women with functional hypothalamic amenorrhea: a systematic review of the literature","volume":"19","author":"Vescovi","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2011.05.016_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bjsm.2005.020065","article-title":"Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review","volume":"40","author":"Liu","year":"2006","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2009.04.004","article-title":"A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms","volume":"310","author":"Confavreux","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2011.05.016_bb0075","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2006.10.008","article-title":"Convergence between bone and energy homeostases: leptin regulation of bone mass","volume":"4","author":"Karsenty","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tem.2008.02.006","article-title":"Reciprocal regulation of bone and energy metabolism","volume":"19","author":"Lee","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/jc.2009-2304","article-title":"Endocrine manifestations of eating disorders","volume":"96","author":"Warren","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0090","doi-asserted-by":"crossref","unstructured":"Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci U S A 2011 In press: doi: 10.1073\/pnas.1015674108.","DOI":"10.1073\/pnas.1015674108"},{"key":"10.1016\/j.metabol.2011.05.016_bb0095","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(05)66830-4","article-title":"Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa","volume":"366","author":"Chan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2011.05.016_bb0105","doi-asserted-by":"crossref","unstructured":"Iwaniec UT, Boghossian S, Trevisiol CH, et al. Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats. J Bone Miner Res 2011; doi: 10.1002\/jbmr.1365.","DOI":"10.1002\/jbmr.365"},{"key":"10.1016\/j.metabol.2011.05.016_bb0110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.060709","article-title":"Leptin inhibits bone formation not only in rodents, but also in sheep","volume":"21","author":"Pogoda","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2011.05.016_bb0115","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1073\/pnas.0308744101","article-title":"Serum leptin level is a regulator of bone mass","volume":"101","author":"Elefteriou","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2011.05.016_bb0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","article-title":"Leptin regulates bone formation via the sympathetic nervous system","volume":"111","author":"Takeda","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2011.05.016_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2011.05.016_bb0130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2011.05.016_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2265.2006.02684.x","article-title":"Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans","volume":"66","author":"Chan","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2011.05.016_bb0140","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/endo.140.4.6637","article-title":"Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2011.05.016_bb0145","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1359\/jbmr.2002.17.6.1034","article-title":"Leptin acts as a growth factor on the chondrocytes of skeletal growth centers","volume":"17","author":"Maor","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2011.05.016_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","article-title":"Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo","volume":"175","author":"Cornish","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2011.05.016_bb0155","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.10156","article-title":"Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling","volume":"85","author":"Gordeladze","year":"2002","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metabol.2011.05.016_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-0115(00)00152-X","article-title":"Leptin is a potent stimulator of bone growth in ob\/ob mice","volume":"92","author":"Steppan","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.metabol.2011.05.016_bb0165","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/endo.142.8.8346","article-title":"Leptin reduces ovariectomy-induced bone loss in rats","volume":"142","author":"Burguera","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2011.05.016_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2011.05.016_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00441-006-0312-3","article-title":"Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow","volume":"327","author":"Hamrick","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.metabol.2011.05.016_bb0180","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1359\/JBMR.050103","article-title":"Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob\/ob mice","volume":"20","author":"Hamrick","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2011.05.016_bb0185","series-title":"Bone densitometry in clinical practice. Application and interpretation","author":"Bonnick","year":"2004"},{"key":"10.1016\/j.metabol.2011.05.016_bb0190","first-page":"1155","article-title":"Bone turnover in cortical and trabecular bone in normal women and in women with osteoporosis","volume":"35","author":"Israel","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","article-title":"Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases","volume":"47","author":"Miyauchi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2011.05.016_bb0200","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1185\/03007995.2010.524121","article-title":"Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study","volume":"26","author":"Zanchetta","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.metabol.2011.05.016_bb0205","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1001\/archinte.1996.00440180051005","article-title":"Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy","volume":"156","author":"Cumming","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.contraception.2005.03.007","article-title":"Effects of an oral contraceptive (norgestimate\/ethinyl estradiol) on bone mineral density in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study","volume":"72","author":"Warren","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.metabol.2011.05.016_bb0215","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1515\/JPEM.2006.19.12.1405","article-title":"The effect of life-long thyroxine treatment and physical activity on bone mineral density in young adult women with congenital hypothyroidism","volume":"19","author":"Kempers","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/0003-4819-121-9-199411010-00007","article-title":"Treating a patient with the Werner syndrome and osteoporosis using recombinant human insulin-like growth factor","volume":"121","author":"Rubin","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2011.05.016_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/endo-114-2-477","article-title":"Cortisol decreases bone formation by inhibiting periosteal cell proliferation","volume":"114","author":"Chyun","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2011.05.016_bb0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2005.02281.x","article-title":"Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study","volume":"62","author":"Cooper","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2011.05.016_bb0235","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00198-007-0514-x","article-title":"Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome","volume":"19","author":"Futo","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2011.05.016_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/oby.2011.40","article-title":"Impact of intra- and extra-osseous soft tissue composition on changes in bone mineral density with weight loss and regain","author":"Bosy-Westphal","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2011.05.016_bb0245","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.beem.2008.07.003","article-title":"Bone mass and architecture determination: state of the art","volume":"22","author":"Griffith","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0250","first-page":"1060","article-title":"Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects","volume":"75","author":"Theintz","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1043-2760(00)00336-2","article-title":"Acquisition of optimal bone mass in childhood and adolescence","volume":"12","author":"Bachrach","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0260","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2011.05.016_bb0265","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2011.05.016_bb0270","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.1986.03380030082032","article-title":"Bone mineral density after resumption of menses in amenorrheic athletes","volume":"256","author":"Drinkwater","year":"1986","journal-title":"JAMA"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049511001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049511001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:52:36Z","timestamp":1758426756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049511001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0026049511001569"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2011.05.016","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2011.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}